AmplifyBio offers preclinical general toxicology services with strategic input from proof-of-concept studies to GLP-regulated studies. Ensure therapeutic programs are relevant and applicable with guidance and insights from our knowledgeable multidisciplinary team. Our experienced team of toxicologists partners with you throughout the entire process, from study design to completion, offering expert support every step of the way. Contact AmplifyBio to initiate your preclinical toxicology studies
AmplifyBio offers in vivo preclinical toxicology services with supportive, technical, and strategic input from proof-of-concept studies to advanced GLP regulated studies. Tell us your goals; we will help you design the path.
Our experts have cultivated decades of experience as members of the Battelle organization, and since AmplifyBio’s spin-out in 2021, we’ve added to our expertise innovative tools and laboratories to meet commercially focused goals.
Preclinical CRO services play a crucial role in drug development by conducting studies and experiments on potential therapeutics before they advance to clinical trials. AmplifyBio offers a wide-range of preclinical CRO services including:
As an expert contract research organization (CRO), AmplifyBio leverages decades of experience to create modern commercial drug development solutions. From CRO and preclinical CRO needs to cell and gene therapy and advanced therapy testing, our accredited team designs innovative paths to produce globally recognized studies, services, and more.